Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS
· Delayed Price · Currency is USD
1.775
-0.005 (-0.28%)
Apr 17, 2025, 4:00 PM EDT
Medexus Pharmaceuticals Employees
Medexus Pharmaceuticals had 82 employees as of March 31, 2024. The number of employees decreased by 16 or -16.33% compared to the previous year.
Employees
82
Change (1Y)
-16
Growth (1Y)
-16.33%
Revenue / Employee
$1,335,854
Profits / Employee
$43,439
Market Cap
59.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Longduoduo Company | 49 |
Medexus Pharmaceuticals News
- 11 days ago - Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection - Newsfile Corp
- 5 weeks ago - Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp. - Newsfile Corp
- 7 weeks ago - Medexus Announces Commercial Availability of GRAFAPEX (treosulfan) for Injection - Newsfile Corp
- 2 months ago - Medexus Pharmaceuticals, Inc. (MEDXF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States - Newsfile Corp
- 2 months ago - Medexus and Ontario's Provincial Health Services Successfully Complete Agreements for Public Reimbursement of Trecondyv (treosulfan for injection) in Ontario, Canada - Newsfile Corp
- 2 months ago - Medexus Schedules Third Fiscal Quarter 2025 Conference Call - Newsfile Corp
- 2 months ago - Medexus Pharmaceuticals Announces Closing of $30 Million Overnight Marketed Public Offering of Common Shares - Newsfile Corp